Cipla Limited
CIPLA · NSE · Pharmaceuticals & Healthcare
About the company
Cipla is among India's oldest and most respected pharmaceutical companies, known for making HIV/AIDS medicines accessible globally in the early 2000s. It manufactures branded and generic medicines across respiratory, anti-infectives, cardiovascular, and urology segments. Cipla exports to over 100 countries and is expanding in the US specialty and biosimilar markets.
| Exchange | NSE |
| Ticker | CIPLA |
| Sector | Pharmaceuticals & Healthcare |
| Indicative market cap USD | $12.50B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (NSE), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- National Stock Exchange of India — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in India
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.